Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | October 2010

Minor Stroke Versus CNI in CREST

Cranial nerve injury should be included in a 30-day neurological outcomes composite endpoint in carotid revascularization.

By Mandy J. Binning, MD, and L. Nelson Hopkins, MD

evt | Article | May 2007

Stroke Roundtable

Leading stroke interventionists discuss lessons learned from the past 10 years, future directions of stroke technology, and how best to treat an acute stroke patient when every second counts.

By Joe Broderick, MD, Gary Duckwiler, MD, Lee R. Guterman, PhD, MD, L. Nelson Hopkins III, MD, Kieran P. Murphy, MD

evt | Article | October 2010

Perspectives on the Current State of Major Carotid Revascularization Trials

A multidisciplinary roundtable of carotid experts discusses recent trial data, difficulties in comparative analyses, the search for definitive conclusions, and the new questions arising with every published dataset.

By William A. Gray, MD; L. Nelson Hopkins, MD; Barry T. Katzen, MD, FACC, FACR, FSIR; Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD; and Frank J. Veith, MD

evt | Article | November 2008

Simulation for Neurointervention

Simulators serve as a valuable training aid for new neurointerventional fellows and others who may be inexperienced with catheter-endovascular techniques.

By Christopher S. Ogilvy, MD; Rodney M. Samuelson, MD; Bernard R. Bendok, MD; Kenneth V. Snyder, MD, PhD; Gursant S. Atwal, BS; Alexander M. Morrison; Adnan H. Siddiqui, MD, PhD; L. Nelson Hopkins, MD; and Elad I. Levy, MD

Advertisement

Advertisement

evt | Article | September 2009

Current Perspective on Self-Expanding Stents for Acute Ischemic Stroke

Experience with this technique and a preview of the first FDA-approved prospective trial, SARIS.

By Elad I. Levy, MD, FACS, FAHA; Sabareesh K. Natarajan, MD, MS; Adnan H. Siddiqui, MD, PhD; Kenneth V. Snyder, MD, PhD; Erik F. Hauck, MD, PhD; J Mocco, MD, MS; and L. Nelson Hopkins, MD, FACS

evt | Article | September 2011

Myocardial Infarction After CAS and CEA: Why Does It Matter?

Clinical or subclinical MI predicts mortality after carotid intervention and should be included in the primary endpoint composite of carotid trials.

By Peter Kan, MD, MPH; Travis M. Dumont, MD; Adib A. Anla, MD; Adnan H. Siddiqui, MD, PhD; Elad I. Levy, MD; and L. Nelson Hopkins, MD

evt | News | November 27, 2014

CABANA Data Published for Boston Scientific's Carotid Wallstent With FilterWire EZ System

November 28, 2014—The results of the prospective, multicenter, nonrandomized CABANA study were published by L. Nelson Hopkins, MD, et al in Catheterization and Cardiovascular Interventions (2014;84:997–1004). The background of the study is that there is a need for additional evidence evaluating carotid artery stenting (CAS) performed by operators with various experience and training levels, stated the investigators.

evt | News | November 7, 2011

Boston Scientific's Postapproval CABANA Study of Carotid Wallstent Presented at TCT

November 8, 2011—Boston Scientific Corporation (Natick, MA) announced positive outcomes from the CABANA postapproval study of the company's carotid Wallstent Monorail endoprosthesis used in conjunction with its FilterWire EZ embolic protection system in routine clinical practice.

evt | News | October 21, 2009

Results Show Mo.Ma Is Safe and Effective for High-Surgical-Risk Patients Undergoing CAS

October 22, 2009—Investigators for the ARMOUR (Proximal Protection with the Mo.Ma Device During Carotid Stenting) trial report that using the Mo.Ma Ultra proximal protection device (Invatec, Inc., Bethlehem, PA) for carotid artery stenting (CAS) in high-surgical-risk patients with US Food and Drug Administration (FDA)–approved carotid stents is safe and effective.

evt | News | October 3, 2024

Synchron’s Brain-Computer Interface Evaluated in COMMAND Early Feasibility Study

October 3, 2024—Synchron recently announced positive results from the COMMAND early feasibility study, which is evaluating the safety and efficacy of the Synchron brain computer interface (BCI, called the Stentrode) in six patients over a 12-month period.

evt | Article | May 2007

Stroke Management

By John R. Laird, Jr, MD, Chief Medical Editor

Sponsored by Contego Medical, Inc.

evt | Article | November 2024 Supplement

Embracing a New Era: Putting Data Into Practice

Dr. Silver moderates a panel of experts who discuss their experiences with the Neuroguard IEP® System, insights into the data, device design characteristics, and impact on the field.

By Mitchell J. Silver, DO, FACC, FSVM, RPVI; Gary Ansel, MD; William A. Gray, MD, MSCAI, FACC; Elad I. Levy, MD, MBA; Sean P. Lyden, MD; S. Jay Mathews, MD, FACC, FSCAI; Robert Mendes, MD, FACS; D. Christopher Metzger, MD, FACC; Kenneth Rosenfield, MD, MHCDS; Adnan H. Siddiqui, MD, PhD; and Peter A. Soukas, MD

evt | Article | June 2011

An Interview with Lee R. Guterman, PhD, MD

A medical technology enthusiast and expert neurointerventionist discusses his interest in device development and what's needed to find the Holy Grail of intracranial aneurysm treatment.

evt | News | May 5, 2011

FDA Expands Indication for Abbott Vascular's RX Acculink for CAS on Standard-Risk Patients

May 6, 2011—Abbott Vascular (Santa Clara, CA) announced that the US Food and Drug Administration (FDA) expanded the approval of the RX Acculink carotid stent system for use in the endovascular treatment of patients with carotid artery disease who are at standard risk for adverse events from carotid endarterectomy (CEA).

evt | News | October 22, 2009

FDA Clears Invatec's Mo.Ma Ultra Proximal Cerebral Protection Device

October 23, 2009—Invatec (Bethlehem, PA) announced that it has received 510(k) clearance from the US Food and Drug Administration to market its Mo.Ma Ultra proximal cerebral protection device for use during carotid artery stenting procedures.

evt | News | October 31, 2009

FDA Clears Invatec's Mo.Ma Ultra Proximal Cerebral EPS

October 23, 2009—Invatec (Bethlehem, PA) announced that it has received 510(k) clearance from the US Food and Drug Administration to market its Mo.Ma Ultra proximal cerebral protection device for use during carotid artery stenting procedures.

evt | News | March 20, 2023

Synchron’s COMMAND Trial of Brain-Computer Interface Enrolls Patients at the Gates Vascular Institute

March 20, 2023—Synchron, an endovascular brain-computer interface (BCI) company developing technology to restore functionality in patients with severe paralysis, announced that the COMMAND trial is commencing enrollment at its third approved site, the Gates Vascular Institute, which is a Kaleida Health facility and a teaching affiliate of the Jacobs School of Medicine and Biomedical Sciences of the University at Buffalo in Buffalo, New York.

evt | News | May 25, 2010

Abbott Vascular to Seek Expanded Indication for CAS With Acculink System Based on CREST Data

May 26, 2010—Abbott Vascular (Santa Clara, CA) announced that based on the strength of data from the CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial) study, which used the company's Acculink carotid stent system and Accunet embolic protection system, the company will seek an expanded indication from the US Food and Drug Administration (FDA) for the Acculink carotid stent system as a treatment option for patients at standard surgical risk.

evt | News | November 8, 2009

VIVA 2009 Late-Breaking Trials Highlight Advances in Interventional Treatments of Peripheral Vascular Disease

November 9, 2009—VIVA Physicians, Inc. (San Jose, CA) announced that the latest data from seven studies focused on the treatment of peripheral arterial disease were presented in the late-breaking trials session of the VIVA 2009: Vascular Interventional Advances annual meeting held on October 19 through 23 in Las Vegas, Nevada.

evt | Article | September 2009

The Neurovascular Frontier

By Lee R. Guterman, PhD, MD - Guest Chief Medical Editor


1
2

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button